{"slideshow_credits": null, "snippet": "In trying to fend off Teva, the drug maker is sending a message that may set off a shareholder revolt.", "abstract": null, "section_name": "Business Day", "print_page": null, "document_type": "article", "byline": {"person": [{"lastname": "SOLOMON", "rank": 1, "firstname": "Steven", "role": "reported", "organization": "", "middlename": "Davidoff"}], "original": "By STEVEN DAVIDOFF SOLOMON"}, "web_url": "http://www.nytimes.com/2015/05/09/business/dealbook/mylans-too-harsh-takeover-defense.html", "lead_paragraph": "In trying to fend off Teva, the drug maker is sending a message that may set off a shareholder revolt.", "headline": {"main": "Mylan\u2019s Too-Harsh Takeover Defense", "content_kicker": "Deal Professor", "kicker": "Deal Professor"}, "_id": "554d0e3c38f0d8188877cc0a", "word_count": "1429", "multimedia": [], "pub_date": "2015-05-09T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "1"}, {"name": "organizations", "value": "Mylan Inc", "is_major": "N", "rank": "2"}, {"name": "organizations", "value": "Perrigo Company", "is_major": "N", "rank": "3"}, {"name": "organizations", "value": "Teva Pharmaceutical Industries Ltd", "is_major": "N", "rank": "4"}, {"name": "persons", "value": "Bresch, Heather", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}